From Digital Health alchemy to chemistry

Digital health and connected drug delivery systems promise a revolution in patient selfcare and outcomes. The road hasn’t been straightforward. The quest for the right solution may sometimes appear more alchemical than scientific.

But it doesn’t have to be. The reaction between pharma and technology requires more than a mix of ingredients; it demands a precise understanding of the subtle chemistry that binds them.

Access webinar recording

This webinar hosted by Ypsomed and S3 Connected Health together with Impatient Health sheds light on how alignment of visions, complementarity of strengths, and a mutual commitment to innovation can catalyse transformative digital health solutions for connected drug delivery systems that deliver on the promise of a revolution in patient selfcare.

Topics:

• How to get the right mix of ingredients to successfully reach market and scale
• When and how pharma should partner with existing digital health platforms to accelerate market access
• What capabilities pharma should have in a partner strategy
• How to deliver long lasting value to patients
• How real-world data can help guide all stakeholders to success
  
  

Experts:

• Florian Kuehni, Ypsomed, Product Area Head Digital Health
• Andrew Tubb, S3 Connected Health, Director, Product Management
• Leslie Anne Fendt, Roche, Global Program Lead, Remote Vision Monitoring
• Paul Upham, Roche, Global Head of Smart Devices
• Paul Simms, Impatient Health, Chief Executive